Tamara Maes
Förmögenhet: 8 M $ per 2026-07-31
Förmögenhet: 8 M $ per 2026-07-31
Tamara Maes was the founder of Oryzon Genomics SA, holding the title of First Deputy Chairman from 2000 to 2025.
Current jobs include Director at Mendelion Lifesciences SL, Member at Alzheimers Drug Discovery Foundation since 2016, and Scientific Coordinator at Oncnosis Pharma AIE.
Education includes a doctorate from Ghent University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ORYZON GENOMICS SA 2,83 % | 2026-07-06 | 2 390 000 ( 2,83 % ) | 8 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
Oncnosis Pharma AIE | Företagsledare/Principal | - |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Constructs commercial buildings | Direktör/Styrelseledamot | - |
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology Operates as a research organisation | Företagsledare/Principal | 2016-01-01 |
| Företag | Position | Slut |
|---|---|---|
| ORYZON GENOMICS S.A. | Grundare | 2025-02-28 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Oryzon Genomics SA
Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology Operates as a research organisation | Health Technology |
Oncnosis Pharma AIE | |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Constructs commercial buildings | Industrial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån